Issue of Equity and Total Voting Rights

Octopus Apollo VCT PLC issued and allotted 7,783,426 new ordinary shares on 1 July 2026 at 50.6p each as part of its £75m offer (with a £25m over-allotment facility) for the 2025/26 and 2026/27 tax years. This represents the final allotment under the subscription offer, with FCA Official List and London Stock Exchange admission expected to start around 3 July 2026. Total issued share capital and total voting rights are now 1,186,636,110 shares.

Analysis

This reads as a technical close, not a fundamental surprise. The main effect is that the fund now has fresh capital to deploy, which is slightly supportive for fee-bearing assets and for the broader VCT financing ecosystem, but the economics are already pre-committed and therefore should not move intrinsic value much after issue costs. For holders, the more important variable is whether the new cash can be put to work fast enough to avoid cash drag; if deployment lags, the fundraising will look more dilutive in hindsight than it does today.

Second-order, the successful close is a mild positive for the wider tax-advantaged retail complex: it suggests distributor appetite and end-investor demand have not been crushed by higher rates. That is constructive for the best-capitalized, best-marketed VCT platforms, while weaker peers with poorer liquidity or less brand reach may have to offer wider discounts or slower fundraises to compete for the same retail wallet. The real read-through is therefore competitive, not company-specific.

The contrarian point is that markets will likely over-interpret the event because it is a clean headline and a visible admission date. In reality, the trading window is short: any price reaction should be mostly days-long and liquidity-driven, while the true catalyst path is 1-3 months of deployment updates and 6-18 months of NAV realization. Falsifiers for a positive read are simple: post-admission weakness that persists below issue economics, or a softer next fundraising season across the VCT peer set.

Key Decisions for Investors

• EXSR: no pre-admission directional trade; wait 3-5 sessions after trading starts and only consider a small tactical long if liquidity normalizes and the stock trades at a discount to issue economics. Treat this as a short-duration trade, not a core position.
• EXSR: if the share price cannot hold post-listing and stays weak for 1-2 weeks, fade the move rather than average down; that would signal insufficient retail absorption and a higher probability of cash-drag disappointment.
• Sector watch: prefer the largest, best-distributed VCT platforms over smaller peers with thinner secondary liquidity. If this close is followed by strong sector demand, use any strength to rotate toward names with better fee leverage and tighter discounts, not the most promotional issuers.
• LSEGY: no direct trade on this print; any impact to London listing activity is too small to matter unless broader VCT and small-cap issuance stays elevated for multiple months.